Furthermore, pasireotide treatment in human healthy volunteers resulted in hyperglycemia that was associated with marked decreases in insulin secretion and incretin responses, but only mild suppression of glucagon secretion and with no effect on insulin sensitivity (55), and pasireotide treatment in mice has also been reported to result in hyperglycemia due to decreased circulating insulin concentrations (40). Here, INS is linked to Hyperglycemia.